Comparative analytical profiling of bevacizumab biosimilars marketed in India: a national control laboratory study
Sign Up to like & getrecommendations! Published in 2020 at "3 Biotech"
DOI: 10.1007/s13205-020-02506-9
Abstract: In this study, analytical profiling of the bevacizumab (BVZ) biosimilars (N = 3) approved in India were evaluated for charge heterogeneity, isoelectric focusing, aggregation and in vitro potency analysis. The charge variants were characterized using high performance… read more here.
Keywords: bevacizumab biosimilars; national control; study; profiling bevacizumab ... See more keywords